Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid Neoplasm.
- Author:
Hye Seon OH
1
;
Hyemi KWON
;
Suyeon PARK
;
Mijin KIM
;
Min Ji JEON
;
Tae Yong KIM
;
Young Kee SHONG
;
Won Bae KIM
;
Jene CHOI
;
Won Gu KIM
;
Dong Eun SONG
Author Information
- Publication Type:Original Article
- Keywords: Immunohistochemistry; Sanger sequencing; BRAF; Mutation; Thyroid neoplasms
- MeSH: Biopsy, Fine-Needle; Biopsy, Large-Core Needle; Humans; Immunohistochemistry*; Methods; Sensitivity and Specificity; Thyroid Gland*; Thyroid Neoplasms*
- From:Endocrinology and Metabolism 2018;33(1):62-69
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: The BRAF V600E mutation is the most common genetic alteration identified in papillary thyroid carcinoma (PTC). Because of its costs effectiveness and sensitivity, direct Sanger sequencing has several limitations. The aim of this study was to evaluate the efficiency of immunohistochemistry (IHC) as an alternative method to detect the BRAF V600E mutation in preoperative and postoperative tissue samples. METHODS: We evaluated 71 patients who underwent thyroid surgery with the result of direct sequencing of the BRAF V600E mutation. IHC staining of the BRAF V600E mutation was performed in 49 preoperative and 23 postoperative thyroid specimens. RESULTS: Sixty-two patients (87.3%) had PTC, and of these, BRAF V600E was confirmed by direct sequencing in 57 patients (91.9%). In 23 postoperative tissue samples, the BRAF V600E mutation was detected in 16 samples (70%) by direct sequencing and 18 samples (78%) by IHC. In 24 fine needle aspiration (FNA) samples, BRAF V600E was detected in 18 samples (75%) by direct sequencing and 16 samples (67%) by IHC. In 25 core needle biopsy (CNB) samples, the BRAF V600E mutation was detected in 15 samples (60%) by direct sequencing and 16 samples (64%) by IHC. The sensitivity and specificity of IHC for detecting the BRAF V600E mutation were 77.8% and 66.7% in FNA samples and 99.3% and 80.0% in CNB samples. CONCLUSION: IHC could be an alternative method to direct Sanger sequencing for BRAF V600E mutation detection both in postoperative and preoperative samples. However, application of IHC to detect the BRAF V600E mutation in FNA samples is of limited value compared with direct sequencing.
